Evidence map›Paper›PMID 41734380›Full record

ArticleACS applied materials & interfaces2026

Multifunctional Selenium-Sulfur-Doped Carbon Dots Nanozymes with Thioredoxin Reductase Activity for Regenerative Therapy of Infected Wounds.

Jie Huang, Na Zhou, Mengmeng Cao, Xiaohan Zhang, Shujian Zhang, Xinrui Luan, Xuancheng Wei, Licheng Wang, Wenxuan Zhang, Zansheng Huang and 4 more

Abstract read
In one paragraph

Article in ACS applied materials & interfaces, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Jie HuangHeilongjiang Provincial Key Laboratory of Hard Tissue Development and Regeneration, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China.
Na ZhouHeilongjiang Provincial Key Laboratory of Hard Tissue Development and Regeneration, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China.
Mengmeng CaoHeilongjiang Provincial Key Laboratory of Hard Tissue Development and Regeneration, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China.
Xiaohan ZhangHeilongjiang Provincial Key Laboratory of Hard Tissue Development and Regeneration, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China.
Shujian ZhangQingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), Qingdao, Shandong 266001, China.
Xinrui LuanHeilongjiang Provincial Key Laboratory of Hard Tissue Development and Regeneration, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China.
Xuancheng WeiHeilongjiang Provincial Key Laboratory of Hard Tissue Development and Regeneration, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China.
Licheng WangHeilongjiang Provincial Key Laboratory of Hard Tissue Development and Regeneration, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China.
Wenxuan ZhangHeilongjiang Provincial Key Laboratory of Hard Tissue Development and Regeneration, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China.
Zansheng HuangHeilongjiang Provincial Key Laboratory of Hard Tissue Development and Regeneration, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China.
Xinhua ShaoCenter for Endemic Disease Control, Chinese Center for Disease Control and Prevention, Harbin Medical University, Harbin, Heilongjiang 150081, China.
Li GaoDepartment of Oral and Maxillofacial, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China.
Ying LiHeilongjiang Provincial Key Laboratory of Hard Tissue Development and Regeneration, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China.
Han JinHeilongjiang Provincial Key Laboratory of Hard Tissue Development and Regeneration, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China.ORCID 0000-0002-6877-6433

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacterial-infected wounds exhibit delayed healing due to numerous pathological factors, including excessive inflammatory responses, reactive oxygen species (ROS) accumulation, and impaired angiogenesis. Current clinical therapies predominantly employ antimicrobial monotherapy, failing to address the complex interplay among the other pathogenic factors. Herein, we synthesized multifunctional selenium-sulfur-doped carbon dots (SE/S-CDs) nanozymes using selenocystine and cysteine as precursors to simultaneously target multiple pathological hallmarks of infected wounds. Primarily, SE/S-CDs exerted potent antibacterial activity by compromising the integrity of bacterial cell membranes, thereby achieving robust pathogen clearance in infected wounds. Furthermore, owing to the presence of Se-S dynamic bonds, they can specifically activate the thioredoxin reductase (TrxR) pathway, efficiently scavenging ROS and alleviating the inflammatory response. In addition, SE/S-CDs upregulated the hypoxia-inducible factor 1α (HIF-1α) signaling pathway, promoting the expression of proangiogenic genes and accelerating neovascularization and tissue repair. Collectively, SE/S-CDs modulated the infected wound microenvironment through a coordinated "antibacterial-anti-inflammatory-antioxidant-proangiogenic" cascade, demonstrating excellent, integrated therapeutic outcomes. This integrated therapeutic strategy not only exhibits efficacy in infected wound treatment but also holds translational potential for other infection-related and oxidative stress-driven diseases.

Indexed as

Anti-Bacterial AgentsSeleniumThioredoxin-Disulfide ReductaseWound InfectionAnimalsCarbonCarbon Quantum DotsHumansMiceNeovascularization, PhysiologicReactive Oxygen SpeciesStaphylococcus aureusSulfurWound HealingAnti-Bacterial AgentsCarbonReactive Oxygen SpeciesSeleniumSulfurThioredoxin-Disulfide Reductasecarbon dotsinfected woundsmultimodal therapynanozymesthioredoxin reductase

Identifiers

PMID41734380
PMCPMC13022815

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.